Crossmark

Cardiotoxicity of adjuvant chemotherapy with trastuzumab: a Japanese claim-based data analysis

Crossref DOI link: https://doi.org/10.1136/openhrt-2022-002053

Published Online: 2022-08-22

Published Print: 2022-08

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Ohtsu, Hiroshi https://orcid.org/0000-0003-3261-8828
Shimomura, Akihiko https://orcid.org/0000-0002-2557-8170
Miyazaki, Sakiko

Yonemoto, Naohiro

Ueda, Shinichiro

Shimizu, Chikako

Sase, Kazuhiro https://orcid.org/0000-0002-2714-304X
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development (20ck0106633h0001)

Japan Society for the Promotion of Science (KAKENHI 18K12134, 20K08427)

Ministry of Health, Labour and Welfare (20FA1018, 20KC2009)
License Information

License valid from 2022-08-22